Literature DB >> 22154592

Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama.

Vicente Bayard1, Rodrigo DeAntonio, Rodolfo Contreras, Olga Tinajero, Maria Mercedes Castrejon, Eduardo Ortega-Barría, Romulo E Colindres.   

Abstract

BACKGROUND: Rotavirus vaccination was introduced in Panama in March 2006. This study was carried out in order to describe the trends in gastroenteritis-related (GER) hospitalizations and mortality in children <5 years of age during the pre- and post-vaccination periods.
METHODS: Data from the Expanded Program on Immunization (Ministry of Health) were used to calculate vaccine coverage. GER mortality and hospitalizations were obtained through database review of the Contraloría General de la República and hospital discharge databases of five sentinel hospitals, for the period 2000-2008. Mean rates of GER mortality and mean numbers of hospitalizations during the baseline pre-vaccination period (2000-2005) were compared to those of 2007 and 2008.
RESULTS: National coverage for the second rotavirus vaccine dose increased from 30% in 2006 to 62% in 2007 and 71% in 2008, varying from 62% in the West region to 77% in the Panama region. Overall, at 2-years post-vaccine introduction, the GER mortality rate in Panama had decreased by 50% (95% confidence interval (CI) 46-54). During 2000-2005, the GER mortality rate in children (<1 year) was 73/100 000, decreasing by 45% (95% CI 40-51) in 2008. In children aged 1-4 years, the GER mortality rate was 20.3/100 000 (2000-2005), decreasing by 54% (95% CI 48-60) in 2008. The Panama region registered the highest mortality rate reduction (69%; 95% CI 58-81) for 2008. During 2008, GER hospitalizations among children <5 years of age decreased by 30% (95% CI 21-37) from the mean number of hospitalizations during 2000-2005.
CONCLUSIONS: A substantial reduction in GER mortality and hospitalizations was observed following the introduction of rotavirus vaccine in Panama.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22154592     DOI: 10.1016/j.ijid.2011.09.003

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  15 in total

1.  Evaluation of the Influence of Gastrointestinal Coinfections on Rotavirus Vaccine Effectiveness in Botswana.

Authors:  Margaret Mokomane; Jacqueline E Tate; Andrew P Steenhoff; Mathew D Esona; Michael D Bowen; Kwana Lechiile; Jeffrey M Pernica; Ishmael Kasvosve; Umesh D Parashar; David M Goldfarb
Journal:  Pediatr Infect Dis J       Date:  2018-03       Impact factor: 2.129

Review 2.  Rotavirus vaccines: current status and future considerations.

Authors:  Catherine Yen; Jacqueline E Tate; Terri B Hyde; Margaret M Cortese; Benjamin A Lopman; Baoming Jiang; Roger I Glass; Umesh D Parashar
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

3.  Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.

Authors:  Gary Dubin; Jean-François Toussaint; Jean-Pol Cassart; Barbara Howe; Donna Boyce; Leonard Friedland; Remon Abu-Elyazeed; Sylviane Poncelet; Htay Htay Han; Serge Debrus
Journal:  Hum Vaccin Immunother       Date:  2013-08-28       Impact factor: 3.452

4.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

5.  Reduction in Diarrhea- and Rotavirus-related Healthcare Visits Among Children <5 Years of Age After National Rotavirus Vaccine Introduction in Zimbabwe.

Authors:  Hilda A Mujuru; Catherine Yen; Kusum J Nathoo; Nhamo A Gonah; Ismail Ticklay; Arnold Mukaratirwa; Chipo Berejena; Ottias Tapfumanei; Kenneth Chindedza; Maxwell Rupfutse; Goitom Weldegebriel; Jason M Mwenda; Eleanor Burnett; Jacqueline E Tate; Umesh D Parashar; Portia Manangazira
Journal:  Pediatr Infect Dis J       Date:  2017-10       Impact factor: 2.129

6.  Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.

Authors:  Naor Bar-Zeev; Lester Kapanda; Jacqueline E Tate; Khuzwayo C Jere; Miren Iturriza-Gomara; Osamu Nakagomi; Charles Mwansambo; Anthony Costello; Umesh D Parashar; Robert S Heyderman; Neil French; Nigel A Cunliffe
Journal:  Lancet Infect Dis       Date:  2015-01-29       Impact factor: 25.071

7.  Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol.

Authors:  Daniel Hungerford; Roberto Vivancos; Neil French; Miren Iturriza-Gomara; Nigel Cunliffe
Journal:  BMJ Open       Date:  2014-11-25       Impact factor: 2.692

8.  Methods and challenges for the health impact assessment of vaccination programs in Latin America.

Authors:  Ana Marli Christovam Sartori; Andréia de Fátima Nascimento; Tânia Yuka Yuba; Patrícia Coelho de Soárez; Hillegonda Maria Dutilh Novaes
Journal:  Rev Saude Publica       Date:  2016-01-15       Impact factor: 2.106

9.  The human rotavirus vaccine Rotarix™ in infants: an integrated analysis of safety and reactogenicity.

Authors:  Hubert Buyse; Carlota Vinals; Naveen Karkada; Htay Htay Han
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

Review 10.  Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis.

Authors:  Victor S Santos; Daniella P Marques; Paulo R S Martins-Filho; Luis E Cuevas; Ricardo Q Gurgel
Journal:  Infect Dis Poverty       Date:  2016-08-12       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.